Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - Avadel Pharmaceuticals plc

23rd Dec 2025 15:00

RNS Number : 7031M
Citadel Group
23 December 2025
 

Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

Citadel Group

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

AVADEL PHARMACEUTICALS PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

N/A

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

22 December 2025

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

 

Class of relevant security (Note 3)

Common Stock ISIN IE00BDGMC594

$0.01 ordinary shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

944,364

0.96

207,382

0.21

(2) Cash-settled derivatives

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

126,400

0.12

749,400

0.76

Total

1,070,764

1.09

956,782

0.97

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

 Common

Buy Transaction

55

21.4000 USD

 Common

Buy Transaction

1

21.4400 USD

 Common

Buy Transaction

4,500

21.4434 USD

 Common

Buy Transaction

10

21.4690 USD

 Common

Buy Transaction

5,000

21.4850 USD

 Common

Buy Transaction

1

21.5000 USD

 Common

Buy Transaction

10

21.5300 USD

 Common

Buy Transaction

1,469

21.5324 USD

 Common

Buy Transaction

1

21.5500 USD

 Common

Buy Transaction

350

21.5550 USD

 Common

Buy Transaction

1,527

21.5581 USD

 Common

Buy Transaction

484

21.5600 USD

 Common

Buy Transaction

272

21.5631 USD

 Common

Buy Transaction

1,226

21.5635 USD

 Common

Buy Transaction

1,357

21.5637 USD

 Common

Buy Transaction

5

21.5640 USD

 Common

Buy Transaction

751

21.5645 USD

 Common

Buy Transaction

611

21.5650 USD

 Common

Buy Transaction

2,771

21.5667 USD

 Common

Buy Transaction

27

21.5667 USD

 Common

Buy Transaction

466

21.5700 USD

 Common

Buy Transaction

208

21.5701 USD

 Common

Buy Transaction

800

21.5701 USD

 Common

Buy Transaction

492

21.5701 USD

 Common

Buy Transaction

796

21.5705 USD

 Common

Buy Transaction

515

21.5706 USD

 Common

Buy Transaction

1,338

21.5725 USD

 Common

Buy Transaction

300

21.5733 USD

 Common

Buy Transaction

59

21.5736 USD

 Common

Buy Transaction

30

21.5747 USD

 Common

Buy Transaction

428

21.5750 USD

 Common

Buy Transaction

200

21.5750 USD

 Common

Buy Transaction

471

21.5750 USD

 Common

Buy Transaction

700

21.5751 USD

 Common

Buy Transaction

57

21.5755 USD

 Common

Buy Transaction

9

21.5756 USD

 Common

Buy Transaction

500

21.5790 USD

 Common

Buy Transaction

66

21.5798 USD

 Common

Buy Transaction

10,583

21.5800 USD

 Common

Buy Transaction

1,600

21.5801 USD

 Common

Buy Transaction

208

21.5804 USD

 Common

Buy Transaction

2,880

21.5816 USD

 Common

Buy Transaction

204

21.5816 USD

 Common

Buy Transaction

1,101

21.5818 USD

 Common

Buy Transaction

2,400

21.5825 USD

 Common

Buy Transaction

3

21.5833 USD

 Common

Buy Transaction

14

21.5843 USD

 Common

Buy Transaction

601

21.5850 USD

 Common

Buy Transaction

3

21.5867 USD

 Common

Buy Transaction

126

21.5888 USD

 Common

Buy Transaction

1

21.5900 USD

 Common

Sell Transaction

1,693

21.4300 USD

 Common

Sell Transaction

940

21.4404 USD

 Common

Sell Transaction

1,082

21.4450 USD

 Common

Sell Transaction

1,325

21.4450 USD

 Common

Sell Transaction

646

21.4483 USD

 Common

Sell Transaction

201

21.4506 USD

 Common

Sell Transaction

217

21.4558 USD

 Common

Sell Transaction

400

21.4675 USD

 Common

Sell Transaction

585

21.4806 USD

 Common

Sell Transaction

300

21.4850 USD

 Common

Sell Transaction

600

21.4855 USD

 Common

Sell Transaction

330

21.4930 USD

 Common

Sell Transaction

45

21.4953 USD

 Common

Sell Transaction

466

21.4979 USD

 Common

Sell Transaction

1

21.5000 USD

 Common

Sell Transaction

900

21.5189 USD

 Common

Sell Transaction

31

21.5266 USD

 Common

Sell Transaction

777

21.5281 USD

 Common

Sell Transaction

418

21.5303 USD

 Common

Sell Transaction

140

21.5443 USD

 Common

Sell Transaction

363

21.5459 USD

 Common

Sell Transaction

12

21.5500 USD

 Common

Sell Transaction

319

21.5543 USD

 Common

Sell Transaction

46

21.5568 USD

 Common

Sell Transaction

145

21.5570 USD

 Common

Sell Transaction

100

21.5600 USD

 Common

Sell Transaction

71

21.5605 USD

 Common

Sell Transaction

11

21.5609 USD

 Common

Sell Transaction

25

21.5652 USD

 Common

Sell Transaction

347

21.5676 USD

 Common

Sell Transaction

703

21.5694 USD

 Common

Sell Transaction

1,147

21.5700 USD

 Common

Sell Transaction

2,891

21.5705 USD

 Common

Sell Transaction

1,618

21.5707 USD

 Common

Sell Transaction

1,211

21.5718 USD

 Common

Sell Transaction

35

21.5731 USD

 Common

Sell Transaction

1,800

21.5733 USD

 Common

Sell Transaction

226

21.5736 USD

 Common

Sell Transaction

104

21.5737 USD

 Common

Sell Transaction

176

21.5738 USD

 Common

Sell Transaction

1,792

21.5743 USD

 Common

Sell Transaction

28

21.5750 USD

 Common

Sell Transaction

105

21.5750 USD

 Common

Sell Transaction

204

21.5757 USD

 Common

Sell Transaction

140

21.5758 USD

 Common

Sell Transaction

526

21.5760 USD

 Common

Sell Transaction

3

21.5767 USD

 Common

Sell Transaction

256

21.5767 USD

 Common

Sell Transaction

33

21.5770 USD

 Common

Sell Transaction

11

21.5773 USD

 Common

Sell Transaction

32

21.5781 USD

 Common

Sell Transaction

113

21.5782 USD

 Common

Sell Transaction

1,104

21.5785 USD

 Common

Sell Transaction

62

21.5785 USD

 Common

Sell Transaction

132

21.5789 USD

 Common

Sell Transaction

143

21.5790 USD

 Common

Sell Transaction

37

21.5795 USD

 Common

Sell Transaction

105

21.5798 USD

 Common

Sell Transaction

276

21.5799 USD

 Common

Sell Transaction

300

21.5799 USD

 Common

Sell Transaction

13,710

21.5800 USD

 Common

Sell Transaction

355

21.5803 USD

 Common

Sell Transaction

821

21.5803 USD

 Common

Sell Transaction

316

21.5805 USD

 Common

Sell Transaction

27

21.5811 USD

 Common

Sell Transaction

1,003

21.5814 USD

 Common

Sell Transaction

1,008

21.5819 USD

 Common

Sell Transaction

26

21.5823 USD

 Common

Sell Transaction

1,009

21.5900 USD

 Common

Sell Transaction

1,944

21.5918 USD

 Common

Sell Transaction

12

21.5950 USD

 Common

Sell Transaction

24,906

21.6000 USD

 Common

Sell Transaction

33

21.6212 USD

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

Common

Call Option

Buy Transaction

1,000

22.5000 USD

American

2027-01-15

0.1100 USD

Common

Call Option

Sell Transaction

2,400

22.5000 USD

American

2026-01-16

0.1000 USD

Common

Call Option

Sell Transaction

200

22.5000 USD

American

2026-03-20

0.1000 USD

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 None

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

YES

 

Date of disclosure

23 December 2025

Contact name

Paula Santos

Telephone number

020 7645 9700

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

 

 

Ap32

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) ANDRULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,TAKEOVER RULES, 2022

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDINGOPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ANDRIGHTS TO SUBSCRIBE FOR NEW SECURITIES

 

1. KEY INFORMATION

 

Full name of person making disclosure:

Citadel Group

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

AVADEL PHARMACEUTICALS PLC

 

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities towhich optionor derivative relates

Exercise price per unit

Type e.g. American, European etc.

Expiry date

Common

Call Option

Purchased

0

25.0 USD

 

American

 

15/01/2027

 

Common

Call Option

Purchased

0

5.0 USD

 

American

 

16/01/2026

 

Common

Put Option

Purchased

0

10.0 USD

 

American

 

20/03/2026

 

Common

Put Option

Purchased

-44,400

10.0 USD

 

American

 

16/01/2026

 

Common

Put Option

Purchased

-3,000

12.5 USD

 

American

 

20/03/2026

 

Common

Put Option

Purchased

-79,400

15.0 USD

 

American

 

16/01/2026

 

Common

Call Option

Purchased

300

22.5 USD

 

American

 

15/01/2027

 

Common

Put Option

Purchased

-100

15.0 USD

 

American

 

15/01/2027

 

Common

Call Option

Purchased

4,400

15.0 USD

 

American

 

15/01/2027

 

Common

Call Option

Purchased

5,600

12.5 USD

 

American

 

15/01/2027

 

Common

Call Option

Purchased

15,600

22.5 USD

 

American

 

20/03/2026

 

Common

Call Option

Purchased

0

25.0 USD

 

American

 

20/03/2026

 

Common

Put Option

Purchased

-200

17.5 USD

 

American

 

20/03/2026

 

Common

Put Option

Purchased

-100

7.5 USD

 

American

 

20/03/2026

 

Common

Put Option

Purchased

-1,000

17.5 USD

 

American

 

18/06/2026

 

Common

Put Option

Purchased

-100

20.0 USD

 

American

 

18/06/2026

 

Common

Put Option

Purchased

0

12.5 USD

 

American

 

15/01/2027

 

Common

Put Option

Purchased

-3,800

15.0 USD

 

American

 

20/03/2026

 

Common

Call Option

Purchased

2,200

20.0 USD

 

American

 

18/06/2026

 

Common

Call Option

Purchased

4,200

17.5 USD

 

American

 

16/01/2026

 

Common

Put Option

Purchased

-900

25.0 USD

 

American

 

20/03/2026

 

Common

Call Option

Sold

-147,800

15.0 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-6,700

20.0 USD

 

American

 

20/03/2026

 

Common

Put Option

Sold

24,900

7.5 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-45,800

20.0 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-12,000

17.5 USD

 

American

 

20/03/2026

 

Common

Put Option

Sold

300

20.0 USD

 

American

 

20/03/2026

 

Common

Call Option

Sold

-2,100

12.5 USD

 

American

 

20/03/2026

 

Common

Call Option

Sold

-2,600

30.0 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-63,600

12.5 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-2,200

25.0 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-100

20.0 USD

 

American

 

15/01/2027

 

Common

Call Option

Sold

-179,300

10.0 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-9,600

7.5 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-7,500

7.5 USD

 

American

 

15/01/2027

 

Common

Call Option

Sold

-54,800

22.5 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-4,800

17.5 USD

 

American

 

15/01/2027

 

Common

Call Option

Sold

-34,000

5.0 USD

 

American

 

15/01/2027

 

Common

Put Option

Sold

4,400

17.5 USD

 

American

 

16/01/2026

 

Common

Put Option

Sold

5,500

12.5 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-13,400

10.0 USD

 

American

 

15/01/2027

 

Common

Call Option

Sold

-100

35.0 USD

 

American

 

16/01/2026

 

Common

Call Option

Sold

-30,000

15.0 USD

 

American

 

20/03/2026

 

Common

Put Option

Sold

59,000

5.0 USD

 

American

 

16/01/2026

 

 

3. AGREEMENTS TO PURCHASE OR SELL

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

Ap33

 

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPTJBTTMTATBIA
FTSE 100 Latest
Value9,875.51
Change-13.71